Literature DB >> 28839305

Clinical and histopathological features of breast cancer in Jordan: Experience from a tertiary care hospital.

Fatima Obeidat1, Mamoun Ahram1, Ali Al Khader1, Khairat Battah1, Mohammad Alchalabi2, Jamal Masad Melhem1, Ahmad Suleiman3.   

Abstract

OBJECTIVE: To analyse breast cancer cases with respect to age, menopausal status, hormone receptors and human epidermal growth factor receptor 2 expression, in addition to nodal and distant metastases.
METHODS: This retrospective study was conducted at Jordan University Hospital, Amman, Jordan, and comprised cases of breast carcinoma among females between 2006 and 2015. Clinicopathological data was collected from patient files and laboratory reports. Data was analysed using SPSS v 17.
RESULTS: Of the 752 cases, 559(74.3%) were invasive ductal carcinomas of non-specific type, followed by 36(4.8%) cases of invasive lobular carcinoma. Upon investigating the clinicopathological data on the breast cancer cases, 466(61.97%) cases had sufficient information for further analysis. Of them, 414(61.97%) patients were aged above 40 years and 190(40.77%) were post-menopausal. Moreover, 221(47.42%) cases showed lymph node metastases, but only 32(6.87%) had distant metastases. The expression of oestrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 was found to be positive in 343(73.6%), 299(66.7%) and 97 (24.6%) cases, respectively. Besides, 42(9.01%) cases were triple negative, which were diagnosed only in females below 40 years age.
CONCLUSIONS: These results were in concordance with international reports, except for the association of triple negative breast cancer with age where it was mainly diagnosed among females younger than 40 years age.

Entities:  

Keywords:  Prevalence, Cancer, Breast carcinoma, Triple negative breast cancer, Poor prognosis.

Mesh:

Substances:

Year:  2017        PMID: 28839305

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab.

Authors:  Basma M Sharaf; Alexander D Giddey; Hasan Alniss; Hamza M Al-Hroub; Raafat El-Awady; Muath Mousa; Ahmed Almehdi; Nelson C Soares; Mohammad H Semreen
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

2.  Epidemiology of women diagnosed with breast cancer in Jordan: A 5-year survival analysis and patients' characteristics from 2 public hospitals.

Authors:  Rimal H Mousa; Jamal M Melhem; Eman A Hammad
Journal:  Saudi Med J       Date:  2021-07       Impact factor: 1.422

3.  Expression of androgen receptor in invasive ductal breast carcinomas: a clinicopathological study from Jordan.

Authors:  Fatima Nouri Obeidat; Mamoun Ahram; Ali Al-Khader; Suzan Al Mbaideen; Huda Hassan; Bushra Altarawneh; Khairat Battah
Journal:  Ann Saudi Med       Date:  2018 Sep-Oct       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.